Stevens Capital Management LP Moderna, Inc. Transaction History

Stevens Capital Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$69.51 - $104.43 $1.99 Million - $2.99 Million	-28,660 Reduced 79.42%	7,426 $739,000
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $2.27 Million - $2.99 Million	23,583 Added 188.62%	36,086 $3.73 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $3.24 Million - $4.39 Million	-27,374 Reduced 68.65%	12,503 $1.52 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $4.03 Million - $5.86 Million	29,724 Added 292.76%	39,877 $6.12 Million
Q4 2022 Feb 06, 2023	BUY	$118.38 - $210.04 $1.2 Million - $2.13 Million	10,153 New	10,153 $1.82 Million
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $3.68 Million - $5.55 Million	31,427 Added 138.28%	54,154 $7.74 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $20,739 - $38,548	164 Added 0.73%	22,727 $3.92 Million
Q4 2021 Jan 28, 2022	BUY	$225.82 - $368.51 $5.1 Million - $8.31 Million	22,563 New	22,563 $5.73 Million
Q3 2019 Nov 08, 2019	SELL	$12.26 - $18.07 $922,552 - $1.36 Million	-75,249 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$13.7 - $28.34 $1.03 Million - $2.13 Million	75,249 New	75,249 $1.1 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.